| Methods |
Women 'randomly allocated' to 2 groups. Method of randomisation not reported |
| Participants |
103 women attending an MCH hospital, Hubei, China. Women had regular menstrual periods and a single act of unprotected intercourse within 96 h of attending the clinic |
| Interventions |
Mife 25 mg vs Mife 10 mg, single dose, orally |
| Outcomes |
Observed number of pregnancies, side effects and changes in menstrual pattern |
| Notes |
Loss to follow‐up total 5 women, 6 women excluded after randomisation Observed pregnancy/expected pregnancy/total number of women: Mife 25 mg 0/3/53; Mife 10 mg 1/2/39 |
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Random sequence generation (selection bias) |
Unclear risk |
Mentioned randomisation but description not adequate |
| Allocation concealment (selection bias) |
Unclear risk |
Method of allocation concealment not mentioned |
| Blinding (performance bias and detection bias)
All outcomes |
Unclear risk |
Not mentioned |
| Incomplete outcome data (attrition bias)
All outcomes |
Low risk |
Post‐randomisation exclusion and loss to follow‐up were reported |
| Selective reporting (reporting bias) |
Low risk |
Planned outcome of pregnancy rate was reported |
| Other bias |
Low risk |
None detected |
